Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Vet Ophthalmol. 2010 Jul;13(4):211–218. doi: 10.1111/j.1463-5224.2010.00782.x

Figure 2.

Figure 2

Phase-contrast light microscopy images of ECF. No morphological changes to ECF were observed when 0.02% of MMC early (A) or late (B) treatment was performed, thus establishing MMC safety to ECF in-vitro. Bar = 100μm